SCHEMBL1331216

SCHEMBL1331216

C[C@@H](NCC=Cc1cccc(C(F)(F)F)c1)c1cccc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 9/20 0.58
ADRA2C P18825 2/20 0.58
SLC6A2 P23975 2/20 0.58
HTR2C P28335 2/20 0.58
SLC6A4 P31645 2/20 0.58
OPRM1 P35372 2/20 0.58
DRD3 P35462 2/20 0.58
MLNR O43193 1/20 0.58
ABCB11 O95342 1/20 0.58
ADRB1 P08588 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
CYP2D6 P10635 1/20 0.58
CHRM1 P11229 1/20 0.58
DRD2 P14416 1/20 0.58
CHRM3 P20309 1/20 0.58
GLRA1 P23415 1/20 0.58
AVPR2 P30518 1/20 0.58
HRH1 P35367 1/20 0.58
MC3R P41968 1/20 0.58
HTT P42858 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1491266 1.00 CASR (0.58) CASRADRA2CSLC6A2HTR2CSLC6A4
SCHEMBL1491268 1.00 CASR (0.58) CASRADRA2CSLC6A2HTR2CSLC6A4
SCHEMBL1331214 1.00 CASR (0.58) CASRADRA2CSLC6A2HTR2CSLC6A4
Bromide SCHEMBL1504865 0.99 CASR (0.57) CASRADRA2CSLC6A2HTR2CSLC6A4
Hydrochloric Acid SCHEMBL1505053 0.99 CASR (0.59) CASRADRA2CSLC6A2HTR2CSLC6A4
Hydrochloric Acid SCHEMBL2873634 0.99 CASR (0.59) CASRADRA2CSLC6A2HTR2CSLC6A4
Hydrochloric Acid SCHEMBL1505054 0.99 CASR (0.59) CASRADRA2CSLC6A2HTR2CSLC6A4
Hydrochloric Acid SCHEMBL2873629 0.99 CASR (0.59) CASRADRA2CSLC6A2HTR2CSLC6A4
Bromide SCHEMBL1504864 0.99 CASR (0.57) CASRADRA2CSLC6A2HTR2CSLC6A4
Phosphoric Acid SCHEMBL15556906 0.94 CASR (0.53) CASRADRA2CSLC6A2HTR2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321256-B1 PROCESS FOR THE SYNTHESIS OF CINACALCET HYDROCHLORIDE ERREGIERRE SPA (IT) 2014-11-12 EP claimed
US-8614354-B2 Process for the synthesis of cinacalcet hydrochloride ERREGIERRE S.P.A. (IT) 2013-12-24 US claimed
US-20120309842-A1 PROCESSES FOR THE PREPARATION OF CINACALCET RANBAXY LABORATORIES LIMITED (IN) 2012-12-06 US claimed
EP-2477959-A1 PROCESSES FOR THE PREPARATION OF CINACALCET Ranbaxy Laboratories Limited (IN) 2012-07-25 EP claimed
EP-2321256-A1 A PROCESS FOR THE SYNTHESIS OF CINACALCET HYDROCHLORIDE ERREGIERRE S.p.A. (IT) 2011-05-18 EP claimed
US-20110105799-A1 PROCESS FOR THE SYNTHESIS OF CINACALCET HYDROCHLORIDE ERREGIERRE S.P.A. 2011-05-05 US claimed
WO-2011033473-A1 PROCESSES FOR THE PREPARATION OF CINACALCET RANBAXY LABORATORIES LIMITED (IN) 2011-03-24 WO claimed
WO-2009153814-A1 A PROCESS FOR THE SYNTHESIS OF CINACALCET HYDROCHLORIDE ERREGIERRE S.P.A. (IT) 2009-12-23 WO claimed
US-9522869-B2 Process for preparing Cinacalcet hydrochloride ZACH SYSTEM S.P.A. (IT) 2016-12-20 US disclosed
EP-2170805-B1 METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF AMGEN INC (US) 2016-03-16 EP disclosed
US-20150152040-A1 Method For The Preparation Of Cinacalcet And Intermediates And Impurities Thereof AMNEAL PHARMACEUTICALS LLC (US) 2015-06-04 US disclosed
US-8969623-B2 Method for the preparation of cinacalcet and intermediates and impurities thereof Amneal Pharmaceuticals, LLC (US) 2015-03-03 US disclosed
EP-2321256-B1 PROCESS FOR THE SYNTHESIS OF CINACALCET HYDROCHLORIDE ERREGIERRE SPA (IT) 2014-11-12 EP disclosed
US-20140296574-A1 PROCESS FOR PREPARING CINACALCET HYDROCHLORIDE F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) 2014-10-02 US disclosed
WO-2010049293-A2 PROCESS FOR PREPARING CINACALCET ZACH SYSTEM S.P.A. (IT) 2010-05-06 WO disclosed
EP-2170805-A2 METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF Amgen Inc. (US) 2010-04-07 EP disclosed
WO-2009153814-A1 A PROCESS FOR THE SYNTHESIS OF CINACALCET HYDROCHLORIDE ERREGIERRE S.P.A. (IT) 2009-12-23 WO disclosed
WO-2009153814-A1 A PROCESS FOR THE SYNTHESIS OF CINACALCET HYDROCHLORIDE ERREGIERRE S.P.A. (IT) 2009-12-23 WO disclosed
US-20090137837-A1 METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF AMGEN INC. 2009-05-28 US disclosed
WO-2009002427-A2 METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF AMGEN INC. (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309842-A1 PROCESSES FOR THE PREPARATION OF CINACALCET CA4, SI, CA9 CASR 147/4885ADRA2C 1904/4885SLC6A2 968/4885
US-20140296574-A1 PROCESS FOR PREPARING CINACALCET HYDROCHLORIDE SLC5A1, CA9, REN CASR 207/4885ADRA2C 657/4885SLC6A2 323/4885
US-20090137837-A1 METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF ACE, SI, REN CASR 71/4885ADRA2C 1439/4885SLC6A2 330/4885
US-20110105799-A1 PROCESS FOR THE SYNTHESIS OF CINACALCET HYDROCHLORIDE CA4, CA14, CA12 CASR 271/4885ADRA2C 1723/4885SLC6A2 466/4885
US-20150152040-A1 Method For The Preparation Of Cinacalcet And Intermediates And Impurities Thereof CMA1, SI, ALDH1A1 CASR 1464/4885ADRA2C 267/4885SLC6A2 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.